BioDelivery Sciences International Inc
NASDAQ:BDSI
Relative Value
There is not enough data to reliably calculate the relative value of BDSI.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
BDSI Competitors Multiples
BioDelivery Sciences International Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
BioDelivery Sciences International Inc
NASDAQ:BDSI
|
552.6m USD | 3.3 | 6.5 | 11.1 | 13.3 | ||
JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 211 733 | -5 347 888.9 | -5 459 134.4 | -5 046 864.6 | |
US |
Eli Lilly and Co
NYSE:LLY
|
739.8B USD | 20.6 | 120.5 | 59 | 67.1 | ||
DK |
Novo Nordisk A/S
CSE:NOVO B
|
4T DKK | 16.2 | 44.3 | 33 | 36.2 | ||
UK |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 | -15 783.5 | 3 846.3 | 17 702.3 | ||
US |
Johnson & Johnson
NYSE:JNJ
|
358.6B USD | 4.2 | 9.3 | 11.5 | 15 | ||
US |
Merck & Co Inc
NYSE:MRK
|
328.3B USD | 5.3 | 142.4 | 35.5 | 57.9 | ||
UK |
AstraZeneca PLC
LSE:AZN
|
190.1B GBP | 5 | 37.5 | 174.5 | 278.3 | ||
CH |
Roche Holding AG
SIX:ROG
|
177.1B CHF | 3 | 15.4 | 8.8 | 10.4 | ||
CH |
Novartis AG
SIX:NOVN
|
177.1B CHF | 3.3 | 11.1 | 8.5 | 12.4 | ||
US |
Pfizer Inc
NYSE:PFE
|
158.9B USD | 2.9 | -514.2 | 12.8 | 20.3 |